The Institute of Cancer Research
The Institute of Cancer Research (ICR), London, is one of the world’s most influential cancer research institutes. We are passionate about our mission to make the discoveries that defeat cancer. Our aim is to deliver excellent research for the benefit of patients and our track record in discovering and developing new targeted drugs is unrivalled in academia. Together with our hospital partner, The Royal Marsden (RMH), we are the largest comprehensive cancer centre in Europe and rated in the top four cancer centres globally.
We aim to improve outcomes for children and teenagers with cancer by helping them live longer and by improving their quality of life – important steps towards our ultimate goal – to cure cancer. The ICR’s Professor Louis Chesler is working to understand the biology of children’s cancers and use that information to discover and develop new personalised approaches to cancer treatment. His research involves the three most common solid tumours of children – neuroblastoma, a nerve tumour, rhabdomyosarcoma, a muscle tumour, and medulloblastoma, a brain tumour. He leads the Paediatric Solid Tumour Biology and Therapeutics Group at the ICR.
The Brain Tumour Charity
The Brain Tumour Charity is the world’s leading brain tumour charity and the largest dedicated funder of research into brain tumours globally.
Committed to saving and improving lives, we’re moving further, faster to help every single person affected by a brain tumour. We’re set on finding new treatments, offering the highest level of support and driving urgent change. And we’re doing it right now. Because we understand that when you, or someone you love, is diagnosed with a brain tumour – a cure really can’t wait.
The Gilbertson Lab
Cancer Research UK Cambridge Institute, University of Cambridge
Professor Richard Gilbertson FRS FMedSci FRCP is a Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. He is the Li Ka Shing Chair of Oncology, Head of the Department of Oncology, and Director of the CRUK Cambridge Major Centre and the CRUK Children’s Brain Tumour Centre of Excellence.
Canceragogo is following his pioneering work on Virtual Brain Tumours for Therapeutic Discovery and AI-driven advances in cancer research.
Research summary of Gilbertson Group – Cellular and molecular origins of cancer
Our research focuses on understanding the origins of cancer, both in children and adults. Our studies of childhood brain tumours seek to understand how these tumours are born in the developing brain, and therefore how we can better classify and treat these diseases; generating cures that have minimal long-term side effects. Since development continues from birth throughout aging, we are applying similar principals to understand the origins and treatment of cancers in adults.